The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women’s Cancer Center Multidisciplinary GuidelineAhmed S. Sultan, Hani Mawardi, Glenn J. Hanna et al.|The Oncologist|2017Cited by 96
Nivolumab for Patients With High-Risk Oral LeukoplakiaGlenn J. Hanna, Sook‐Bin Woo, Alessandro Villa et al.|JAMA Oncology|2023Cited by 56
Oral immune‐related adverse events associated with PD‐1 inhibitor therapy: A case seriesMuhammad Ali Shazib, Alessandro Villa, Sook‐Bin Woo et al.|Oral Diseases|2019Cited by 53
Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized LeukoplakiaGlenn J. Hanna, F. Stephen Hodi, Alessandro Villa et al.|Cancer Research Communications|2021Cited by 28
Imiquimod for the treatment of oral leukoplakia: A two‐center retrospective studyHervé Sroussi, Sook‐Bin Woo, Alessandro Villa et al.|Oral Diseases|2024Cited by 10